Part 1. Introduction

• 1.1 Market Definition
• 1.2 Key Benefit
• 1.3 Market Segment

Part 2. Methodology

• 2.1 Primary
• 2.2 Secondary

Part 3. Executive Summary

Part 4. Market Overview

• 4.1 Introduction
• 4.2 Market Size and Forecast
• 4.3 Market Dynamics
  • 4.3.1 Drivers
  • 4.3.2 Restraints
• 4.4 Impact of COVID-19 Pandemic

Part 5. Global Market for Uveitis Treatment by Drug Class

• 5.1 Anti-Inflammatory
  • 5.1.1 Market Size and Forecast
• 5.2 Antimicrobial Drugs
  • 5.2.1 Market Size and Forecast
• 5.3 Immunotherapy & Targeted Therapies
  • 5.3.1 Market Size and Forecast
• 5.4 Others
  • 5.4.1 Market Size and Forecast

Part 6. Global Market for Uveitis Treatment by Disease Type

• 6.1 Anterior Uveitis
  • 6.1.1 Market Size and Forecast
• 6.2 Intermediate Uveitis
  • 6.2.1 Market Size and Forecast
• 6.3 Panuveitis
  • 6.3.1 Market Size and Forecast
• 6.4 Posterior Uveitis
  • 6.4.1 Market Size and Forecast
• 6.5 Others
  • 6.5.1 Market Size and Forecast

Part 7. Global Market for Uveitis Treatment by Distribution Channel

• 7.1 Drug Stores And Retail Pharmacies
  • 7.1.1 Market Size and Forecast
• 7.2 Hospital Pharmacies
  • 7.2.1 Market Size and Forecast
• 7.3 Online
  • 7.3.1 Market Size and Forecast
• 7.4 Others
  • 7.4.1 Market Size and Forecast

Part 8. Global Market for Uveitis Treatment by Region

• 8.1 Asia-Pacific
  • 8.1.1 Market Size and Forecast
• 8.2 Europe
  • 8.2.1 Market Size and Forecast
• 8.3 North America
  • 8.3.1 Market Size and Forecast
• 8.4 Middle East And Africa (Mea)
  • 8.4.1 Market Size and Forecast
• 8.5 South America
  • 8.5.1 Market Size and Forecast

Part 9. Key Competitor Profiles

• 9.1 Abbvie Inc.
• 9.2 Actavis plc
• 9.3 Alimera Sciences, Inc.
• 9.4 Amgen Inc.
• 9.5 Bausch Health Companies Inc.
• 9.6 Clearside Biomedical, Inc.
• 9.7 Eye Point Pharmaceuticals Securities Corporation
• 9.8 Mylan N.V.
• 9.9 Novartis International AG
• 9.10 Santen Pharmaceutical Co., Ltd.

*LIST IS NOT EXHAUSTIVE

Part 10. Patent Analysis

• 10.1 Patent Statistics
• 10.2 Regional Analysis
• 10.3 Trends Analysis

DISCLAIMER

ABOUT GEN CONSULTING COMPANY

The global uveitis treatment market is projected to grow at a compound annual growth rate (CAGR) of 5.11% during the forecast period 2021-2027, according to the new report published by Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global uveitis treatment market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, company share of market leaders, growth rate and market segments.

The uveitis treatment market is segmented on the basis of drug class, disease type, distribution channel, and region. The uveitis treatment market is segmented as below:

By Drug Class:
- anti-inflammatory
- antimicrobial drugs
- immunotherapy & targeted therapies
- others

By Disease Type:
- anterior uveitis
- intermediate uveitis
- panuveitis
- posterior uveitis
- others

By Distribution Channel:
- drug stores and retail pharmacies
- hospital pharmacies
- online
- others

By Region:
- region
- Asia-Pacific
- Europe
- North America
- Middle East and Africa (MEA)
- South America

The market research report covers the analysis of key stake holders of the uveitis treatment market. Some of the leading players profiled in the report include Abbvie Inc., Actavis plc, Alimera Sciences, Inc., Amgen Inc., Bausch Health Companies Inc., Clearside Biomedical, Inc., Eye Point Pharmaceuticals Securities Corporation, Mylan N.V., Novartis International AG, Santen Pharmaceutical Co., Ltd., among others.
*list is not exhaustive, request free sample to get a complete list of companies

Historical & Forecast Period
This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Scope of the Report
- To analyze and forecast the market size of the global uveitis treatment market.
- To classify and forecast the global uveitis treatment market based on drug class, disease type, distribution channel, and region.
- To identify drivers and challenges for the global uveitis treatment market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global uveitis treatment market.
- To conduct pricing analysis for the global uveitis treatment market.
- To identify and analyze the profile of leading players operating in the global uveitis treatment market.

Why Choose This Report
- Gain a reliable outlook of the global uveitis treatment market forecasts from 2021 to 2027 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.